Introduction: Postmenopausal osteoporosis as a major public health issue

Journal of Managed Care Pharmacy

Volumn 12, Issue 6 SUPPL., 2006, Pages

  Kamel, Hosam K ^a   O'Connell, Mary Beth ^b  

^a St Joseph's Mercy Health Center Hot Springs   (United States)

^b WAYNE STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOCHEMICAL MARKER; VITAMIN D;

AGING; BONE DENSITY; BONE MASS; BONE RADIOGRAPHY; BONE REMODELING; CALCIUM INTAKE; DISEASE PREDISPOSITION; DRUG EFFICACY; DRUG SAFETY; FRACTURE; HEALTH CARE COST; HEALTH PROGRAM; HIP FRACTURE; HUMAN; LIFESTYLE MODIFICATION; MEDICAL INFORMATION; NUTRITIONAL ASSESSMENT; OSTEOLYSIS; OUTCOME ASSESSMENT; POSTMENOPAUSE OSTEOPOROSIS; QUALITY OF LIFE; REVIEW; RISK FACTOR; VERTEBRA FRACTURE; VITAMIN INTAKE;

EID: 34548655887     PISSN: 10834087     EISSN: None     Source Type: Journal    
DOI: 10.18553/jmcp.2006.12.s6-a.s2     Document Type: Review

References (14)

1. National Osteoporosis Foundation. Fast facts. Available at: http://www.nof.org/osteoporosis/diseasefacts.htm. Accessed April 18, 2006.
2. Hodgson SF, Watts NB, Bilezikian JP, et al., for the AACE Osteoporosis Task Force. American Association of Clinical Endocrinologists medical guidelines for clinical practice for the prevention and treatment of postmenopausal osteoporosis: 2001 edition, with selected updates for 2003. Endocr Pract. 2003;9:544-64.
3. National Osteoporosis Foundation. Physician's guide to prevention and treatment of osteoporosis. Available at: http://www.nof.org/professionals/ clinical.htm. Accessed April 18, 2006.
4. Follin SL, Black JN, McDermott MT. Lack of diagnosis and treatment of osteoporosis in men and women after hip fracture. Pharmacotherapy. 2003;23:190-98.
5. Riley RL, Carnes ML, Gudmundsson A, Elliott ME. Outcomes and secondary prevention strategies for male hip fractures. Ann Pharmacother. 2002;36:17-23.
6. Gardner MJ, Brophy RH, Demetrakopoulos D, et al. Interventions to improve osteoporosis treatment following hip fracture. A prospective, randomized trial. J Bone Joint Surg Am. 2005;87:3-7.
7. Cerulli J, Zeolla MM. Impact and feasibility of a community pharmacy bone mineral density screening and education program. J Am Pharm Assoc. 2004;44:161-67.
8. Tosteson AN, Grove MR, Hammond CS, et al. Early discontinuation of treatment for osteoporosis. Am J Med. 2003;115:209-16.
9. McCombs JS, Thiebaud P, McLaughlin-Miley C, Shi J. Compliance with drug therapies for the treatment and prevention of osteoporosis. Maturitas. 2004;48:271-87.
10. Good moves for life: welcome to the United States bone and joint decade! Available at: http://www.usbjd.org/. Accessed April 24, 2006.
11. U.S. Department of Health and Human Services. Bone health and osteoporosis: a report of the Surgeon General (2004). Available at: http://www.surgeongeneral.gov/library/bonehealth/content.html. Accessed April 26, 2006.
12. U.S. Department of Health and Human Services. The 2004 Surgeon General's report on bone health and osteoporosis: what it means to you. Available at: http://hhs.gov/surgeongeneral/library/bonehealth/docs/OsteoBrochure1mar05.pdf. Accessed April 20, 2006.
13. National Committee for Quality Assurance. The Health Plan Employer Data and Information Set. Available at: http://www.ncqa.org/programs/hedis/. Accessed April 24, 2006.
14. Centers for Medicare & Medicaid Services. Physician voluntary reporting program: overview. Available at: http://www.cms.hhs.gov/PVRP/ 01_Overview.asp. Accessed April 20, 2006.